Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention

Background. Concomitant use of rifamycins to treat or prevent tuberculosis can result in subtherapeutic concentrations of antiretroviral drugs. We studied the interaction of efavirenz with daily rifapentine and isoniazid in human immunodeficiency virus (HIV)–infected individuals receiving a 4-week r...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Infect Dis
Главные авторы: Podany, Anthony T., Bao, Yajing, Swindells, Susan, Chaisson, Richard E., Andersen, Janet W., Mwelase, Thando, Supparatpinyo, Khuanchai, Mohapi, Lerato, Gupta, Amita, Benson, Constance A., Kim, Peter, Fletcher, Courtney V.
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2015
Предметы:
HIV/AIDS
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4583578/
https://ncbi.nlm.nih.gov/pubmed/26082504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ464
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы